Whole blood serotonin and tryptophan levels in Tourette's disorder: effects of acute and chronic clonidine treatment |
| |
Authors: | J F Leckman G M Anderson D J Cohen S Ort D F Harcherik E L Hoder B A Shaywitz |
| |
Institution: | 1. The Child Study Center, Yale University School of Medicine, New Haven, CT 06510, USA;2. Children''s Clinical Research Center, Yale University School of Medicine, New Haven, CT 06510, USA;3. Departments of Psychiatry, Yale University School of Medicine, New Haven, CT 06510, USA;4. Pediatrics, Yale University School of Medicine, New Haven, CT 06510, USA;5. Laboratory Medicine, Yale University School of Medicine, New Haven, CT 06510, USA;6. Neurology, Yale University School of Medicine, New Haven, CT 06510, USA |
| |
Abstract: | Whole blood serotonin (WB5HT) and tryptophan (WBTRP) levels were studied in 20 patients (aged 8 to 45 years) with Tourette's disorder under medication-free baseline conditions and following acute and chronic clonidine treatment. Compared to 87 normal controls, Tourette's disorder patients had lower mean baseline WBTRP levels (mean +/- SEM: Tourette's, 5993 +/- 304 ng/ml vs. 6822 +/- 169 ng/ml; p less than .03). No significant differences in mean baseline WB5HT levels were found. Three hours after an acute dose of clonidine (2.5 - 5.1 micrograms/kg, p.o. at 9:00 A.M.), no mean differences were observed (baseline vs. post 3 hours) in WB5HT or WBTRP levels. However, following chronic treatment (greater than 3 weeks) with clonidine (3-8 micrograms/kg/day, p.o.), WB5HT levels were increased in 9 of 14 Tourette's disorder patients. The mean increases in WB5HT levels following chronic clonidine treatment were significant when WB5HT levels were expressed per 10(9) platelets. (mean +/- SEM: baseline, 471 +/- 45 ng/10(9) platelets vs. chronic, 697 +/- 82 ng/10(9) platelets, p = .02). No mean differences in WBTRP levels were observed after chronic clonidine treatment. These findings are discussed in light of a proposed intermediary role of 5HT systems in the mode of action of clonidine in the treatment of Tourette's disorder. |
| |
Keywords: | |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|